Contract Research Organization (CRO) Mass Spectroscopy Services Market Report 2025

The contract research organization (CRO) mass spectroscopy services market size has grown rapidly in recent years. It will grow from $1.6 billion in 2024 to $1.81 billion in 2025 at a compound annual growth rate (CAGR) of 13.3%. The growth in the historic period can be attributed to the increasing drug discovery activities, the rise in the development of targeted therapies, expansion in diagnostic testing, growing global demand for CRO-based analytical services, and the growth of cross-border clinical trial activities.

The contract research organization (CRO) mass spectroscopy services market size is expected to see rapid growth in the next few years. It will grow to $2.94 billion in 2029 at a compound annual growth rate (CAGR) of 12.9%. The growth in the forecast period can be attributed to the increasing complexity of drug discovery pipelines, the expansion of pharmaceutical and biotechnology industries, the rising prevalence of chronic diseases, the growing adoption of personalized medicine, and higher research and development expenditures. Key trends expected during the forecast period include technological advancements, adoption of high-resolution mass spectrometry, implementation of top-down proteomics, utilization of artificial intelligence, and the integration of cloud-based data management solutions.

The growing pharmaceutical and biotechnology industries are expected to drive the growth of the contract research organization (CRO) mass spectroscopy services market going forward. These industries include organizations involved in discovering, developing, and manufacturing drugs, biologics, and diagnostics to improve patient health outcomes. Growth in these sectors is fueled by increasing investments in research and development, which accelerate the discovery of new drugs and therapies to address complex and unmet medical needs. CRO mass spectroscopy services support these industries by providing precise analytical insights that enhance drug discovery, development, and regulatory compliance. For instance, in June 2023, according to the European Federation of Pharmaceutical Industries and Associations (EFPIA), a Belgium-based organization representing the pharmaceutical sector, European pharmaceutical production increased from \$352.48 billion in 2021 to \$369.95 billion in 2022. Therefore, the expansion of pharmaceutical and biotechnology industries is propelling the growth of the CRO mass spectroscopy services market.

Key companies in the CRO mass spectroscopy services market are focusing on developing advanced platforms, such as next-generation mass spectrometry (MS) software solutions, to improve biomarker discovery, protein quantification, and immunopeptidomics analysis. Next-generation MS software solutions are sophisticated tools designed to enhance the speed, accuracy, and efficiency of data analysis in complex chemical and biological research. For instance, in May 2025, Biognosys AG, a Switzerland-based mass spectrometry solutions company, launched Spectronaut 20 and SpectroMine 5, two advanced MS data analysis platforms setting new benchmarks in immunopeptidomics and data-independent acquisition (DIA) workflows. These AI-enhanced platforms significantly increase sensitivity and accuracy in detecting low-abundance peptides, providing deeper proteome coverage and improved neoantigen identification. By replacing manual, error-prone data interpretation with automated, machine learning-driven analytics, these tools accelerate therapeutic target validation. Their enhanced peptide-spectrum matching engine improves peptide identification and quantification consistency, delivering more reliable and reproducible results in clinical research.

In March 2025, Momentum Biotechnologies, a US-based contract research organization, acquired OmicScouts GmbH for an undisclosed amount. Through this acquisition, Momentum Biotechnologies aims to expand its mass spectrometry-based drug discovery capabilities and strengthen its presence in the European market. OmicScouts GmbH is a Germany-based CRO specializing in mass spectrometry-based proteomics and chemoproteomics services.

Major players in the contract research organization (cro) mass spectroscopy services market are Thermo Fisher Scientific Inc., Laboratory Corporation of America Holdings, ICON Public Limited Company, Eurofins Scientific SE, Charles River Laboratories International Inc., Medpace Holdings Inc., Novatia LLC, Inotiv Inc., BioAgilytix Labs LLC, Altasciences Company Inc., Alliance Pharma Inc., ABC Laboratories Inc., Omics Solutions LLC, Creative Proteomics Inc., Momentum Biotechnologies LLC, Accurant Biotech Inc., Alderley Analytical Limited, Allumiqs Corporation, CovalX AG, MS Bioworks LLC.

North America was the largest region in the contract research organization (CRO) mass spectroscopy services market in 2024. The regions covered in contract research organization (CRO) mass spectroscopy services market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the contract research organization (CRO) mass spectroscopy services market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

Contract research organization (CRO) mass spectrometry services are specialized analytical testing solutions provided by third-party research organizations using mass spectrometry technology to support drug development, clinical research, environmental analysis, and other scientific applications. These services involve the identification, quantification, and structural characterization of chemical compounds, biomolecules, and complex mixtures using high-resolution mass spectrometry techniques.

The key types of CRO mass spectrometry services include proteomics services, metabolomics services, and others. Proteomics services use mass spectrometry to profile proteins in biological samples, assessing their identity, abundance, modifications, and interactions. These services are applied in drug discovery and development, clinical research, preclinical testing, environmental testing, forensic analysis, food safety, and proteomics and genomics studies. Key end users include pharmaceutical and biopharmaceutical companies, medical device manufacturers, and other related organizations.

The contract research organization (CRO) mass spectroscopy services market research report is one of a series of new reports that provides contract research organization (CRO) mass spectroscopy services market statistics, including contract research organization (CRO) mass spectroscopy services industry global market size, regional shares, competitors with a contract research organization (CRO) mass spectroscopy services market share, detailed contract research organization (CRO) mass spectroscopy services market segments, market trends and opportunities, and any further data you may need to thrive in the contract research organization (CRO) mass spectroscopy services industry. This contract research organization (CRO) mass spectroscopy services market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The contract research organization (CRO) mass spectroscopy services market consists of revenues earned by entities by providing services such as biomarker discovery and validation, quality control and stability testing, and clinical sample analysis. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.